Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Critical Care Medicine(Electronic Edition) ›› 2017, Vol. 10 ›› Issue (05): 303-308. doi: 10.3877/cma.j.issn.1674-6880.2017.05.003

Special Issue:

• Original Article • Previous Articles     Next Articles

Expression and clinical significance of serum amyloid beta-protein1-42 in children with lead poisoning

Yimei Jin1,(), Airong Huang1, Dongshi Liang1   

  1. 1. Department of Pediatric Emergency, the Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
  • Received:2017-02-26 Online:2017-10-01 Published:2017-10-01
  • Contact: Yimei Jin
  • About author:
    Corresponding author: Jin Yimei, Email:

Abstract:

Objective

To investigate the expression of serum amyloid beta-protein (Aβ)1-42 in children with lead poisoning and its relationship with the blood lead level.

Methods

Totally 84 cases of children with lead poisoning were enrolled and divided into three groups according to the blood lead levels: the mild group (n = 40), the moderate group (n = 26) and the severe group (n = 18). Meanwhile, 28 healthy children were selected as the control group. Five trace elements (including the blood lead level) were determined by the atomic absorption method; serum levels of Aβ1-42 were tested by enzyme-linked immunosorbent assay. The intelligence scale was to assess children patients' intelligence. After sodium dimercaptosulphonate treatment, the blood lead level and serum Aβ1-42 concentration in children patients were also detected. The correlation was analyzed by Pearson correlation coefficients.

Results

Before treatment, there were significant differences of the blood lead level and serum Aβ1-42 concentration existing in four groups (F = 969.367, 136.678; all P < 0.05); as the level of lead poisoning increased, the blood lead concentration and serum Aβ1-42 in each group increased as well. The blood lead level and serum Aβ1-42 had positive correlation by Pearson correlation analysis (r = 0.893, P < 0.001). Before and after treatment, the blood lead levels in the mild [(219 ± 15) μg/L vs. (174 ± 15) μg/L], moderate [(289 ± 43) μg/L vs. (213 ± 43) μg/L], and severe [(489 ± 40) μg/L vs. (378 ± 44) μg/L] groups changed significantly (t = 15.295, 10.130, 9.237; all P < 0.05); the serum Aβ1-42 concentrations in the mild [(326 ± 43) ng/L vs. (301 ± 33) ng/L], moderate [(392 ± 60) ng/L vs. (342 ± 63) ng/L], and severe [(515 ± 62) ng/L vs. (447 ± 54) ng/L] groups decreased significantly (t = 7.205, 4.350, 7.712; all P < 0.05). With the increased degree of lead poisoning in children patients at different ages, the score of the intelligence scale decreased significantly (all P < 0.05).

Conclusions

The serum Aβ1-42 level can evaluate neurotoxicity caused by lead poisoning. It is an effective way combined with intelligence evaluation in older children.

Key words: Lead poisoning, Amyloid beta-protein, Children

京ICP 备07035254号-20
Copyright © Chinese Journal of Critical Care Medicine(Electronic Edition), All Rights Reserved.
Tel: 0571-87236467 E-mail: zhwzzyxzz@126.com
Powered by Beijing Magtech Co. Ltd